Macrophages in the intestinal mucosa can rapidly engage
Toll-like receptor [TLR]-mediated inflammatory responses to protect against pathogen invasion, but these same innate immune responses can also drive the induction of
colitis. Our previous research revealed that metadherin [MTDH] is overexpressed in multiple
cancers and plays vital roles in tumour progression. However, the role of MTDH in intestinal
inflammation is largely unknown. In this study, we found the MTDH expression in colonic lamina propria [CLP] macrophages was positively correlated with inflammatory
colitis severity. MTDH-/- mice were protected against the symptoms of
dextran sodium sulphate [DSS]-induced
colitis; however, adoptive transfer of MTDH wild-type [WT] monocytes partially restored the susceptibility of MTDH-/- mice to DSS-induced
colitis. TLR stimulation was sufficient to induce the expression of MTDH, whereas the absence of MTDH was sufficient to suppress TLR-induced production of inflammatory
cytokines by macrophages. From a mechanistic perspective, MTDH recruited
TRAF6 to TAK1, leading to TRAF6-mediated TAK1 K63 ubiquitination and phosphorylation, ultimately facilitating TLR-induced NF-κB and MAPK signalling. Taken together, our results indicate that MTDH contributes to
colitis development by promoting TLR-induced pro-inflammatory
cytokine production in CLP macrophages and might represent a potential therapeutic approach for intestine
inflammation intervention.